2 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Withdrawn 2 |
Follow Behavior Therapy: new trials by email Literature Review of Behavior Therapy trials Research Report on Behavior Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes Exenatide-LAR plus Dapagliflozin placebo, Exenatide-LAR plus Dapagliflozin, Insulin Titration - Diabetes Mellitus, Type 2 | Phase 4 | Withdrawn | Weill Medical College of Cornell University | 2016-06-01 | 2017-03-03 | |
| Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole Behavioral Intervention - Substance Abuse, Substance Dependence | Phase 4 | Withdrawn | Northwell Health | 2011-06-01 | 2018-03-19 |
Diabetes Mellitus, Type 2 (1) · Obesity (1) · Substance-Related Disorders (1)
Northwell Health (1) · Weill Medical College of Cornell University (1)
United States (2)
Alpana P Shukla, MD (1) · Serge Sevy, MD, MBA (1)